Yes, you can safely take Avarin (phenprocoumon) and Gaviscon together
There is no documented drug interaction between phenprocoumon and Gaviscon (aluminum hydroxide/magnesium carbonate antacid), and these medications can be taken concurrently without dose adjustment.
Key Clinical Considerations
No Evidence of Interaction
The provided evidence extensively reviews phenprocoumon drug interactions, including interactions with antibiotics, NSAIDs, antiplatelet agents, and proton pump inhibitors 12. Notably absent from all documented interactions is any mention of antacids like Gaviscon affecting phenprocoumon efficacy or safety.
Gaviscon's General Precaution
The FDA label for Gaviscon includes a standard precaution stating "taking a prescription drug. Antacids may interact with certain prescription drugs" 3. However, this is a broad, non-specific warning that applies to potential interactions with some medications (typically through altered absorption), not a contraindication with anticoagulants.
Mechanism Analysis
Phenprocoumon is metabolized hepatically and has documented interactions primarily through:
Gaviscon works locally in the stomach as an antacid/alginate barrier and does not significantly affect hepatic metabolism or anticoagulant pharmacodynamics 5
Practical Recommendations
Take both medications as prescribed without timing separation. Unlike some anticoagulant interactions that require dose spacing (such as verapamil with dabigatran requiring 2-hour separation), no such precaution exists for phenprocoumon and antacids.
Important Monitoring
Continue routine INR monitoring as prescribed for your phenprocoumon therapy. The long half-life of phenprocoumon (5.27-5.29 days) 6 means any true drug interaction would manifest gradually over days to weeks, not acutely.
Common Pitfall to Avoid
Do not confuse this with proton pump inhibitor (PPI) interactions—while high-dose esomeprazole may slightly increase phenprocoumon effects 2, Gaviscon is an antacid with a completely different mechanism and does not share this interaction profile.